Concepedia

Mohamed Wehbe

MW

Statistics

Publications

21

Citations

1.2K

H-Index

19

Active since

2012

Affiliations

BC Cancer Agency(Current)

Vanderbilt University

University of British Columbia

Centre for Drug Research and Development

Vanderbilt University Medical Center

Mohamed Wehbe is an author at BC Cancer Agency specializing in drug delivery, pharmacology, and pharmacy.

ORCID

Publications per year

2012–2024

21

Publications

21

Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma

Lihong Wang-Bishop, Mohamed Wehbe, Daniel Shae et al. · Journal for ImmunoTherapy of Cancer · 2020 · 175 citations · Full text

, , +17

Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines

Daniel Shae, Jessalyn J. Baljon, Mohamed Wehbe et al. · ACS Nano · 2020 · 161 citations · Full text

, , +17

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa et al. · Science Immunology · 2023 · 120 citations · Full text

, , +17

Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration

Mohamed Wehbe, Lihong Wang-Bishop, Kyle W. Becker et al. · Journal of Controlled Release · 2020 · 119 citations · Full text

, , +17

Development of Bacteriostatic DNA Aptamers for Salmonella

Olga S. Kolovskaya, Anna Savitskaya, Tatiana N. Zamay et al. · Journal of Medicinal Chemistry · 2013 · 97 citations

, , +14

1–5 of 21